Sandeep Sahay VIEW CLINICAL PROFILE

Sandeep Sahay, MD, MSc, ATSF

Associate Professor of Medicine, Academic Institute
Associate Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


VIEW CLINICAL PROFILE
Description of Research

Pulmonary Hypertension

Pulmonary Arterial Hypertension

Chronic Thromboembolic Pulmonary Hypertension

Pulmonary Embolism

Interstitial Lung Diseases

Areas Of Expertise

Pulmonary fibrosis Pulmonary hypertension Pulmonary arterial hypertension chronic thromboembolic pulmonary hypertension
Education & Training

MD
Active Clinical Trials

Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso (BREEZE)

NCT03950739

Publications

Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes
Nathan, SD, Deng, C, King, CS, DuBrock, HM, Elwing, J, Rajagopal, S, Rischard, F, Sahay, S, Broderick, M, Shen, E, Smith, P, Tapson, VF & Waxman, AB 2023, , CHEST, vol. 163, no. 2, pp. 398-406. https://doi.org/10.1016/j.chest.2022.09.007

Effects of COVID-19 pandemic on the management of pulmonary hypertension
Zhou, CY, Sahay, S, Shlobin, O, Soto, FJ, Mathai, SC, Melendres-Groves, L, Mullin, CJ, Levine, DJ, Kay, D, Highland, K, Bossone, E, Poms, A, Memon, H, Balasubramanian, V, Farmer, MJS, Rahaghi, F & Elwing, JM 2023, , Respiratory Medicine, vol. 206, 107061. https://doi.org/10.1016/j.rmed.2022.107061

Pulmonary hypertension due to high cardiac output
Qaiser, KN, Sahay, S & Tonelli, AR 2023, , Respiratory Medicine, vol. 206, 107034. https://doi.org/10.1016/j.rmed.2022.107034

Tobacco, second-hand smoke and cancer
Pinkaew, D, Dammad, T, Bitar, M, Sahay, S & Folz, RJ 2022, . in Environmental Oncology. Springer.

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
the INSPIRE study investigators 2022, , Pulmonary Circulation, vol. 12, no. 3, e12119. https://doi.org/10.1002/pul2.12119

Utilization of risk assessment tools in management of PAH: A PAH provider survey
Sahay, S, Balasubramanian, V, Memon, H, Poms, A, Bossone, E, Highland, K, Kay, D, Levine, DJ, Mullin, CJ, Melendres-Groves, L, Mathai, SC, Soto, FJ, Shlobin, O & Elwing, JM 2022, , Pulmonary Circulation, vol. 12, no. 2, e12057. https://doi.org/10.1002/pul2.12057

BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
Spikes, LA, Bajwa, AA, Burger, CD, Desai, SV, Eggert, MS, El-Kersh, KA, Fisher, MR, Johri, S, Joly, JM, Mehta, J, Palevsky, HI, Ramani, GV, Restrepo-Jaramillo, R, Sahay, S, Shah, TG, Deng, C, Miceli, M, Smith, P & Shapiro, SM 2022, , Pulmonary Circulation, vol. 12, no. 2, e12063. https://doi.org/10.1002/pul2.12063

An adult case of NOTCH3 mutation in pulmonary artery hypertension
Padhye, AA & Sahay, S 2022, , Pulmonary Circulation, vol. 12, no. 1, e12050. https://doi.org/10.1002/pul2.12050

E-REVEAL Lite 2.0 scoring for early prediction of disease progression in pulmonary arterial hypertension
Sahay, S, Bhatt, J, Beshay, S, Guha, A, Nguyen, DT, Graviss, EA & Nagueh, SF 2022, , Pulmonary Circulation, vol. 12, no. 1, e12026. https://doi.org/10.1002/pul2.12026

Progression of pulmonary veno-occlusive disease without pulmonary hypertension
Beshay, S, Humbert, M, Barrios, R & Sahay, S 2022, , Pulmonary Circulation, vol. 12, no. 1, e12046. https://doi.org/10.1002/pul2.12046

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study
Rahaghi, FF, Kolaitis, NA, Adegunsoye, A, de Andrade, JA, Flaherty, KR, Lancaster, LH, Lee, JS, Levine, DJ, Preston, IR, Safdar, Z, Saggar, R, Sahay, S, Scholand, MB, Shlobin, OA, Zisman, DA & Nathan, SD 2022, , CHEST, vol. 162, no. 1, pp. 145-155. https://doi.org/10.1016/j.chest.2022.02.012

Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study
Nathan, SD, Waxman, A, Rajagopal, S, Case, A, Johri, S, DuBrock, H, De La Zerda, DJ, Sahay, S, King, C, Melendres-Groves, L, Smith, P, Shen, E, Edwards, LD, Nelsen, A & Tapson, VF 2021, , The Lancet Respiratory Medicine, vol. 9, no. 11, pp. 1266-1274. https://doi.org/10.1016/S2213-2600(21)00165-X

Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?
Piccari, L, Bernardo, RJ, Rodríguez-Chiaradía, D, Vitulo, P, Wort, SJ & Sahay, S 2021, , Pulmonary Circulation, vol. 11, no. 2. https://doi.org/10.1177/20458940211018074

Pregnancy in PAH: Emotions versus reality
Sahay, S & Farber, HW 2021, , Journal of Heart and Lung Transplantation, vol. 40, no. 5, pp. 394-395. https://doi.org/10.1016/j.healun.2021.01.2138

Assessment of pinch force strength in patients with pulmonary arterial hypertension in the era of AOS® dry powder inhaler based therapies
Sahay, S, Holy, R, Lyons, S, Parsley, E, Maurer, M & Weers, J 2021, , Respiratory Medicine, vol. 177, 106308. https://doi.org/10.1016/j.rmed.2021.106308

Impact of inhaled treprostinil on risk stratification with noninvasive parameters: a post hoc analysis of the TRIUMPH and BEAT studies
Tonelli, AR, Sahay, S, Gordon, KW, Edwards, LD, Allmon, AG, Broderick, M & Nelsen, AC 2021, , Pulmonary Circulation, vol. 10, no. 4.

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review
Wesley Milks, M, Sahay, S, Benza, RL & Farber, HW 2021, , Journal of Heart and Lung Transplantation, vol. 40, no. 3, pp. 172-182. https://doi.org/10.1016/j.healun.2020.12.005

G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
Youssef, JG, Zahiruddin, F, Youssef, G, Padmanabhan, S, Ensor, J, Pingali, SR, Zu, Y, Sahay, S & Iyer, SP 2021, , Annals of Hematology, vol. 100, no. 3, pp. 667-673. https://doi.org/10.1007/s00277-021-04395-1

Risk stratification in pulmonary hypertension associated with interstitial lung disease: The holy grail?
Beshay, S & Sahay, S 2021, , Journal of Heart and Lung Transplantation, vol. 40, no. 3, pp. 234-235. https://doi.org/10.1016/j.healun.2020.11.010

Impact of human behavior on inspiratory flow profiles in patients with pulmonary arterial hypertension using AOS™ dry powder inhaler device
Sahay, S, Holy, R, Lyons, S, Parsley, E, Maurer, M & Weers, J 2021, , Pulmonary Circulation, vol. 11, no. 1. https://doi.org/10.1177/2045894020985345

VIEW FULL PUBLICATIONS